๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model

โœ Scribed by Alan S. Bloom; Raymond G. Hoffmann; Scott A. Fuller; John Pankiewicz; Harold H. Harsch; Elliot A. Stein


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
218 KB
Volume
8
Category
Article
ISSN
1065-9471

No coin nor oath required. For personal study only.

โœฆ Synopsis


As the applications of functional magnetic resonance imaging (fMRI) expand, there is a need for the development of new strategies for data extraction and analysis that do not require the presentation of stimuli in a repeated on/off pattern. A description and evaluation of a method and computer algorithm for the detection and analysis of brain activation patterns following acute drug administration using fMRI are presented. A waveform analysis protocol (WAP) input function has been developed that is based upon the single-dose pharmacokinetics of a drug of interest. As a result of this analysis, regional brain activation can be characterized by its localization and intensity of activation, onset of action, time to peak effect, and duration of action. A global statistical test for significant drug effects based upon the probability of a voxel being activated by a saline vehicle injection is applied to grouped data on a voxel by voxel basis. Representative data are presented using nicotine as a prototypical agent. Using this method, statistically significant drug-induced brain activation has been identified in several key cortical and subcortical brain regions.


๐Ÿ“œ SIMILAR VOLUMES


A priori prediction of tissue:plasma par
โœ Patrick Poulin; Frank-Peter Theil ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 374 KB ๐Ÿ‘ 1 views

The tissue:plasma (P t:p ) partition coefficients (PCs) are important drugspecific input parameters in physiologically based pharmacokinetic (PBPK) models used to estimate the disposition of drugs in biota. Until now the use of PBPK models in early stages of the drug discovery process was not possib